Viewing nowCombinationDapagliflozin and Sitagliptin Tablets 10/100 mg
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Myungmoon Pharm Co., Ltd.

MFDS item code 202200067 · Approved 2022.01.04 · Insurance code 649808150
Improvement of glycemic control in patients with type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It is particularly effective when taken in conjunction with dietary therapy and exercise, and is recommended for patients for whom the combination of sitagliptin and dapagliflozin is appropriate. This helps improve blood sugar levels and supports healthy blood sugar management.
One tablet of this medicine may be administered once daily, with or without food, to patients receiving sitagliptin 100 mg and dapagliflozin 10 mg. The tablet should be swallowed whole. Patients with renal impairment The efficacy and safety of this medicine depend on renal function; evaluation of renal function before treatment and periodically after starting treatment is recommended. - No dose adjustment is necessary when the estimated glomerular filtration rate[estimated glomerular filtration rate(eGFR)] is 45 mL/min/1.73m2 or higher. - This medicine should not be administered when the estimated glomerular filtration rate(eGFR) is below 45 mL/min/1.73 m2. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment.
This medication contains the active ingredients sitagliptin and dapagliflozin, which are used in the treatment of diabetes. First, this medication may cause hypersensitivity reactions, so it must be discontinued immediately if allergic reactions occur. Caution is especially needed as anaphylaxis, angioedema, and serious skin conditions may arise. Additionally, acute pancreatitis has been reported rarely, so if abdominal pain, vomiting, or other symptoms occur, consult a doctor immediately. This medication should not be used in patients with type 1 diabetes or those undergoing dialysis, and patients with impaired renal function may require dose adjustment. The dapagliflozin component may induce decreased fluid volume and hypotension; therefore, elderly patients and those taking diuretics should have their blood pressure and fluid status monitored regularly. There may be an increased risk of hypoglycemia when used in conjunction with insulin or sulfonylureas for blood sugar control, necessitating dose adjustment. This medication may increase the risk of genital infections and urinary tract infections, so appropriate treatment should be obtained if infection symptoms appear. It is recommended that women who are pregnant or breastfeeding do not use this medication, and safety in children under 18 years has not been established. There is no specific antidote for overdose, so appropriate treatment should be administered based on symptoms, and some components may be removed by dialysis. There is a risk of hypoglycemia when driving or operating machinery, so caution is advised. Finally, this medication should be stored in its original container, out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will ensure the medication's effectiveness is preserved safely.
Bright yellow rectangular film-coated tablets
Box - 28 tablets/box [(7 tablets/PTP (Alu-Alu) x 4)], Box - 30 tablets/box [(10 tablets/PTP (Alu-Alu) x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Myungmoon Pharm Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Daewoo Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
International Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Shinpoong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
IYON Pharmaceutical Co., Ltd.
CombinationDapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg · Sitagliptin Phosphate Hydrate 128.5mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.